Liquiritigenin-7-O-β-D-glucopyranosyl-(1→2)-β-D-apiofuranoside |
| Catalog No.GC36466 |
Trk-IN-20 es un tipo de derivados de 3-vinilindazol. Trk-IN-20 suprime las funciones de las quinasas Trk mediante la inhibición de la fosforilación de TrkA/B/C con valores IC50 de 1,6 nM, 2,9 nM y 2,0 nM, respectivamente.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 135432-48-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Liquiritigenin-7-O-β-D-glucopyranosyl-(1→2)-β-D-apiofuranoside (Liquiritigenin-7-apiosylglucoside) is a flavonoid isolated from the roots of Glycyrrhiza, has weaker cytotoxicity against several tumor cells and normal cells[1].
[1]. Ohno H, et al. Evaluation of cytotoxiciy and tumor-specificity of licorice flavonoids based on chemical structure. Anticancer Res. 2013 Aug;33(8):3061-8.
Average Rating: 5 (Based on Reviews and 39 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *